Stefan R Bornstein Selected Research

3-methoxytyramine (methoxytyramine)

10/2018	Strain-specific metastatic phenotypes in pheochromocytoma allograft mice
11/2014	In vivo fluorescence imaging and urinary monoamines as surrogate biomarkers of disease progression in a mouse model of pheochromocytoma.
4/2014	Biochemical diagnosis of phaeochromocytoma using plasma-free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions.
7/2012	Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status.
3/2011	Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefan R Bornstein Research Topics

Disease

33	Insulin Resistance 02/2022 - 05/2002
32	Type 2 Diabetes Mellitus (MODY) 01/2022 - 07/2007
31	Pheochromocytoma 01/2022 - 03/2002
28	Neoplasms (Cancer) 01/2022 - 03/2002
24	Obesity 10/2021 - 11/2004
19	Inflammation (Inflammations) 12/2021 - 06/2002
11	Paraganglioma (Paragangliomas) 01/2022 - 03/2002
10	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2020 - 12/2010
9	Sepsis (Septicemia) 01/2019 - 05/2003
8	COVID-19 08/2022 - 01/2020
8	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2017
8	Hypertension (High Blood Pressure) 11/2021 - 11/2004
8	Diabetes Mellitus 10/2020 - 08/2011
7	Adrenocortical Carcinoma 01/2022 - 03/2005
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 09/2006
7	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2022 - 02/2002
7	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2021 - 05/2002
7	Glucose Intolerance 01/2021 - 01/2009
6	Necrosis 01/2022 - 01/2018
6	Infections 01/2022 - 09/2004
6	Fibrosis (Cirrhosis) 11/2021 - 04/2012
6	Body Weight (Weight, Body) 10/2021 - 11/2015
6	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 01/2018 - 02/2002
5	Weight Loss (Weight Reduction) 01/2021 - 05/2017
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 11/2010
5	Hypoglycemia (Reactive Hypoglycemia) 01/2019 - 12/2010
5	Cushing Syndrome 07/2017 - 06/2002
5	Adenoma (Adenomas) 03/2016 - 06/2002
5	Multiple Endocrine Neoplasia Type 2a (MEN 2) 03/2011 - 08/2006
4	Hyperaldosteronism (Conn Syndrome) 01/2022 - 12/2013
4	Parkinson Disease (Parkinson's Disease) 01/2020 - 11/2003
4	Heart Failure 01/2019 - 05/2006
4	Neoplasm Metastasis (Metastasis) 10/2018 - 08/2006
4	Hyperglycemia 09/2017 - 05/2010
4	Hyperplasia 03/2016 - 02/2002
3	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2018
3	Overweight 01/2021 - 11/2004
3	Fatty Liver 01/2020 - 10/2014
3	Dyslipidemias (Dyslipidemia) 12/2019 - 04/2012
3	Ischemia 12/2019 - 01/2005
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 11/2013
3	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 12/2014
3	Panic Disorder (Panic Attack) 01/2018 - 08/2012
3	Hypercholesterolemia 01/2013 - 12/2009
3	Carcinogenesis 01/2013 - 06/2002

Drug/Important Bio-Agent (IBA)

32	Insulin (Novolin)FDA Link 01/2022 - 05/2002
23	Glucose (Dextrose)FDA LinkGeneric 02/2022 - 04/2003
17	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022 - 02/2002
17	CatecholaminesIBA 03/2021 - 09/2004
16	LipidsIBA 01/2020 - 05/2002
15	AldosteroneIBA 08/2020 - 05/2002
13	GlucocorticoidsIBA 01/2022 - 05/2002
13	Hormones (Hormone)IBA 01/2021 - 05/2003
11	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2002
11	Adrenocorticotropic Hormone (ACTH)FDA Link 10/2015 - 02/2002
10	Biomarkers (Surrogate Marker)IBA 12/2021 - 02/2002
10	Toll-Like Receptors (Toll-Like Receptor)IBA 09/2013 - 11/2004
9	Lipoproteins (Lipoprotein)IBA 12/2019 - 07/2012
8	Triglycerides (Triacylglycerol)IBA 10/2021 - 01/2009
8	oxidized low density lipoproteinIBA 01/2020 - 10/2007
7	SteroidsIBA 08/2022 - 11/2004
7	Epinephrine (Adrenaline)FDA LinkGeneric 01/2019 - 08/2006
7	NormetanephrineIBA 10/2018 - 03/2011
6	IronIBA 01/2022 - 03/2011
6	Pharmaceutical PreparationsIBA 01/2022 - 01/2007
6	MetanephrineIBA 01/2019 - 02/2011
5	EnzymesIBA 11/2021 - 09/2004
5	Messenger RNA (mRNA)IBA 01/2021 - 06/2002
5	Blood Glucose (Blood Sugar)IBA 10/2020 - 04/2003
5	3-methoxytyramine (methoxytyramine)IBA 10/2018 - 03/2011
5	Dopamine (Intropin)FDA LinkGeneric 10/2018 - 11/2003
5	Norepinephrine (Noradrenaline)FDA LinkGeneric 10/2018 - 08/2006
5	CorticosteroneIBA 07/2017 - 04/2006
4	Phosphotransferases (Kinase)IBA 03/2022 - 01/2018
4	AntibodiesIBA 01/2022 - 01/2016
4	LDL Lipoproteins (beta Lipoproteins)IBA 01/2020 - 01/2009
4	citrate-binding transport proteinIBA 01/2020 - 12/2015
4	AdiponectinIBA 01/2020 - 01/2011
4	CholesterolIBA 05/2019 - 07/2009
4	Dehydroepiandrosterone (DHEA)IBA 07/2017 - 05/2003
4	Succinate Dehydrogenase (Fumarate Reductase)IBA 02/2015 - 08/2006
4	AndrogensIBA 01/2008 - 05/2002
3	AutoantibodiesIBA 08/2022 - 11/2017
3	nasIBA 01/2022 - 01/2021
3	RNA (Ribonucleic Acid)IBA 10/2021 - 01/2019
3	Protein Kinases (Protein Kinase)IBA 01/2021 - 01/2018
3	LeptinIBA 01/2021 - 05/2002
3	Lipoprotein(a)IBA 01/2020 - 10/2007
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 02/2015
3	MineralocorticoidsIBA 02/2019 - 11/2004
3	Streptozocin (Streptozotocin)FDA Link 01/2018 - 07/2010
3	Fatty Acid-Binding ProteinsIBA 01/2017 - 08/2009
3	CytokinesIBA 09/2013 - 06/2002

Therapy/Procedure

23	Therapeutics 01/2022 - 04/2003
13	Blood Component Removal (Apheresis) 08/2022 - 12/2009
9	Bariatric Surgery 01/2022 - 11/2017
5	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2021 - 01/2018
4	Glycemic Control 08/2019 - 12/2010
4	Transplantation 10/2017 - 01/2010
3	Gastrectomy 11/2019 - 01/2018